Zurn Elkay delivered a positive third quarter, with the market responding well to both higher-than-expected sales and robust non-GAAP profitability. Management credited organic growth, driven by solid execution in nonresidential construction markets, as well as timely pricing actions to offset tariff impacts. CEO Todd Adams highlighted the effectiveness of internal initiatives, stating that core categories experienced "solid unit growth on top of...market, on top of...price," and emphasized continued progress in margin expansion and free cash flow. The company also completed the termination of its U.S. pension plan, removing a significant liability and supporting balance sheet strength.
Is now the time to buy ZWS? Find out in our full research report (it’s free for active Edge members).
Zurn Elkay (ZWS) Q3 CY2025 Highlights:
- Revenue: $455.4 million vs analyst estimates of $442.1 million (11.1% year-on-year growth, 3% beat)
- Adjusted EPS: $0.43 vs analyst estimates of $0.40 (8.6% beat)
- Adjusted EBITDA: $122.2 million vs analyst estimates of $117 million (26.8% margin, 4.5% beat)
- Revenue Guidance for Q4 CY2025 is $398.5 million at the midpoint, above analyst estimates of $389 million
- EBITDA guidance for the full year is $438.5 million at the midpoint, above analyst estimates of $430.5 million
- Operating Margin: 17%, in line with the same quarter last year
- Organic Revenue rose 11% year on year
- Market Capitalization: $7.88 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions.
Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated.
Here is what has caught our attention.
Our Top 5 Analyst Questions From Zurn Elkay’s Q3 Earnings Call
- Bryan Blair (Oppenheimer) asked if growth rates were diverging across legacy Zurn categories and about the outlook for early 2026. CEO Todd Adams responded that unit growth remained solid across core categories and saw no significant change in momentum heading into the next quarter.
- Adam Farley (Stifel) questioned whether Q3 volume growth was pulled forward and sought clarity on Q4 volume expectations. CFO David Pauli confirmed some pull-forward due to a September price increase but emphasized that underlying demand trends remained healthy.
- Michael Pesendorfer (Baird) pressed for more detail on the M&A pipeline and potential moves in hygienic/environmental versus drinking water categories. Adams noted the funnel had grown at the top but remained broad, with no major shift in focus or valuation approach.
- Edward Magi (BNP Paribas) asked about the sustainability of strong margin performance and the company’s advantage in managing tariffs. Pauli said margin expansion is seen as a new baseline, while Adams highlighted supply chain moves out of China as key to navigating tariffs.
- David Tarantino (KeyBanc Capital Markets) inquired about price vs. volume dynamics and prospects for further pricing in 2026. Pauli explained Q3 saw five points of price realization, with more impact expected in the first half of next year and evaluation of further price increases ongoing.
Catalysts in Upcoming Quarters
In the coming quarters, our analysts will be watching (1) the adoption trajectory of new filtration products in both commercial and residential channels, (2) the pace and effectiveness of supply chain realignment out of China to mitigate further tariff shocks, and (3) the resilience of margin expansion efforts as market growth remains modest. Progress toward capturing new business in education and healthcare construction, and the impact of any further pricing actions, will also be closely monitored.
Zurn Elkay currently trades at $47.04, up from $46.06 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
The Best Stocks for High-Quality Investors
Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.